An agreement was reached by OpGen with Thermo Fisher Scientific to allow Thermo Fisher's real-time PCR technology to be used in its line of Acuitas AMR Gene Panel tests. Under the deal, for which terms were undisclosed, OpGen's u5.47 test for multiplex gene detection will incorporate Thermo Fisher's TaqMan Fast Advanced Master Mix and TaqMan probes.
Thermo Fisher's PCR tech to be used in OpGen's gene panel tests
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.